Page 24 - Heca News Today

India's income tax department is conducting searches at Mankind Pharma Ltd's office in New Delhi, two government sources told Reuters on Thursday, days after the condom maker's successful public listing on domestic stock exchanges.

ImmunityBio Inc said on Thursday the U.S. Food and Drug Administration has declined to approve its combination therapy to treat a type of bladder cancer due to deficiencies in the company's application.

Family-owned Italian industrial conglomerate Angelini is set to invest up to $505.5 million to fund development of a new treatment for epilepsy by Japan's JCR Pharmaceuticals , capable of penetrating the blood-brain barrier.

Wide coverage of Alzheimer's drug Leqembi would raise future costs for the U.S. Medicare health plan by $2 billion to $5 billion a year, according to a study led by researchers at the University of California, Los Angeles (UCLA).

A fresh wave of COVID-19 is spreading through China as people return from public holiday travel, reaching trading floors and raising concern of an impact to trading volume - albeit likely not as pronounced as previous pandemic-induced disruption.

Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech potentially bodes well for the future of fighting an extremely aggressive form of cancer after the regimen was shown to trigger a promising immune reaction in some pancreatic cancer patients.

The U.S. Food and Drug Administration's staff reviewers raised concerns over limited data on Sarepta Therapeutics Inc's gene therapy for a muscle-wasting disorder, ahead of a meeting of the agency's advisers on Friday.

The U.S. government on Thursday will end the COVID-19 Public Health Emergency that allowed millions of Americans to receive vaccines, tests and treatments at no cost.

Shares of Manforce condom maker Mankind Pharma Ltd surged as much as 31% in debut trading on Tuesday, valuing the company at 566.43 billion rupees ($6.93 billion) in the country's biggest listing so far this year.

Fresenius Medical Care said on Tuesday labour shortages were slowly easing as the German dialysis specialist reported a drop in first-quarter adjusted operating income that was not as steep as some analysts had expected.